Fuan Pharmaceutical (300194.SZ): Indobufen tablets obtained drug registration certificate.

Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Hubei Renmin Pharmaceutical Co., Ltd. (referred to as "Renmin Pharmaceutical"), recently received a drug registration certificate issued by the National Medical Products Administration. The related drug is called Indobufen Tablets. Indobufen tablets are suitable for ischemic cardiovascular diseases and ischemic cerebrovascular diseases caused by arteriosclerosis, as well as venous thrombosis formation. They can also be used to prevent thrombosis during blood dialysis.